Over the past 10 years, mitochondrial defects have been implicated in a wid
e variety of degenerative diseases, aging, and cancer. Studies on patients
with these diseases have revealed much about the complexities of mitochondr
ial genetics, which involves an interplay between mutations in the mitochon
drial and nuclear genomes. However, the pathophysiology of mitochondrial di
seases has remained perplexing. The essential role of mitochondrial oxidati
ve phosphorylation in cellular energy production, the generation of reactiv
e oxygen species, and the initiation of apoptosis has suggested a number of
novel mechanisms for mitochondrial pathology. The importance and interrela
tionship of these functions are now being studied in mouse models of mitoch
ondrial disease.